The journey from a solo consultant to a multi-million-dollar, 50-person enterprise is a story we hear often in Silicon Valley, typically punctuated by a Series A funding round. The path Vanessa Best took is different, and in its difference lies a masterclass in alternative corporate finance. Her company, Precision HealthCare Consultants, didn’t scale with venture capital. It scaled by leveraging what I’ve come to call “invisible balance sheets”—assets and relationships that traditional lenders and investors often overlook but which can be the most powerful capital of all.
Let’s start with the stark data, because it frames the magnitude of her achievement. According to the 2026 Wells Fargo Impact of Women-Owned Businesses report, the average revenue for Black/African American women-owned employer firms is $650,000. That’s the lowest of any demographic group measured and stands in contrast to the $1.7 million average for white women-owned employers. More critically, the report found that between 2022 and 2025, only women-owned businesses above the $1 million revenue line grew consistently across firm count, employment, and sales. Below that line, growth stalled.
This million-dollar threshold isn’t just a vanity metric. In my years covering corporate growth, I’ve seen it act as a fundamental fault line. It’s the point where a business transitions from being a large job to a self-sustaining economic entity with compounding potential. Crossing it requires a structural shift in operations, financing and strategy. For Best, the single greatest structural barrier was, unsurprisingly, capital access. The national numbers bear this out. In 2024, despite federal guarantees, only 42% of SBA loans went to women-owned businesses and just 30% of private capital-backed firms had women owners.
Faced with this, Best engineered a financial workaround. She built her initial growth capital not from a bank but from a portfolio of certifications: New York State M/WBE, SBA 8(a), HUBZone, WBENC and NMSDC. To the uninitiated, this may sound bureaucratic. In practice, it was a brilliant strategic maneuver. These certifications became her credit score, granting her access to the table for corporate and government prime contracts. As she clarified, the certifications didn’t win the work—her team’s quality did—but they unlocked the bid opportunities.
The real financial ingenuity, however, came next. Those prime contracts led to something more valuable: subcontracting relationships with massive, established organizations. This is a nuance many founders miss. In corporate finance, we talk about “strategic partners,” but this is the raw mechanics of it. By subcontracting, Precision gained an insider’s view into how large institutions budget, prepare proposals and run internal governance. It was a free, high-stakes education in scaling operations, funded by the client’s own procurement process. When a conventional bank line of credit still didn’t materialize, she turned to a Community Development Financial Institution (CDFI), a sector that originated over $24 billion in loans in 2024 precisely for firms bypassed by traditional banks.
The second pillar of her invisible balance sheet was high-value networks. The financial world runs on networks, but not all networks are created equal. Best’s participation in programs like EY’s Entrepreneurs Access Network provided what she described not as an open door, but as “a hallway.” This access translated into introductions to global pharmaceutical companies and even European government contracts. This aligns with research consistently showing that capital disparity is driven less by the quality of ideas and more by limited networks within funding circles. Her recognition by the U.S. Department of Commerce’s Minority Business Development Agency, including being named National Minority Health Care Firm of the Year in 2021, served a similar function, providing both validation and a powerful referral network.
But none of this financial engineering would matter without a fundamentally sound and scalable business model. Precision’s model is a case study in identifying a market failure and building a scalable service around it. The company focuses on including minorities, indigenous populations, rural communities and women in clinical trials—groups historically “forgotten” by large clinical research organizations. Best argues this isn’t merely an ethical or diversity decision; it’s a scientific and commercial imperative. A drug tested on an unrepresentative sample may fail in the real-world market, representing a massive financial and clinical risk for its developer.
Precision sells trust and proximity, which it monetizes through clinical trial recruitment, site identification and regulatory training. Its asset is embedded community relationships, nurse navigators and mobile units. This model creates a durable moat. As Best put it, “Generic clinical trial recruitment just can’t touch these communities, but with us, since we’re part of the community, the trust is already there.” This is a high-margin, repeatable service addressing a critical pain point for a deep-pocketed industry.
Listening to Best reflect on the Wells Fargo data, her reaction was telling. “It’s amazing listening to the statistics,” she said. “How that perfectly reflects my journey.” Then she added, “It’s a reality. So we need to figure out what we do to change it.” Her journey provides the blueprint. It demonstrates that scale can be built by creatively leveraging certification capital, strategic subcontracting, mission-driven CDFI financing and high-trust networks. In an economy that often conflates venture capital with viability, Vanessa Best’s story is a powerful reminder. The most resilient capital structures are often built from the ground up, using the materials the mainstream market has left behind.
- Leverage invisible balance sheets
- Build growth capital through certifications
- Establish subcontracting relationships
- Engage in high-value networks
- Focus on inclusive clinical trials
- Create a scalable business model
| Metric | Black/African American Women | White Women |
|---|---|---|
| Average Revenue | $650,000 | $1.7 million |
| SBA Loan Access in 2024 | 42% | N/A |
| Private Capital-Backed Firms with Women Owners | 30% | N/A |
| Growth of Women-Owned Firms Above $1 Million (2022-2025) | Consistent | Consistent |
| Percentage of Firms Below $1 Million | Stalled | N/A |